H.C. Wainwright Sticks to Its Buy Rating for Vor Biopharma (VOR)

Tip Ranks
2025.11.19 14:15
portai
I'm PortAI, I can summarize articles.

H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating for Vor Biopharma with a price target of $32.00. Ramakanth, a 5-star analyst with a 17.9% average return, focuses on healthcare stocks. The consensus on Vor Biopharma is a Strong Buy with an average price target of $50.33.

H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on Vor Biopharma today and set a price target of $32.00.

TipRanks Black Friday Sale

  • Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
  • Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off

According to TipRanks, Ramakanth is a 5-star analyst with an average return of 17.9% and a 43.00% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as Corcept Therapeutics, Personalis, and Evaxion Biotech.

Currently, the analyst consensus on Vor Biopharma is a Strong Buy with an average price target of $50.33.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.